Background: Aggressive surgical resection of malignant gliomas is a controversial issue in neurosurgery.
Introduction
A long-standing controversy in the neurosurgical literature involves the efficacy of maximally resecting malignant gliomas. In other fields of oncologic surgery, complete resection of the lesion, hopefully with wide margins, is key to controlling the disease, but malignant
Benefits of Maximal Resection

Prolonged Survival
A recent study at The University of Texas M. D. Anderson Cancer Center found that a resection of 98% or more of the tumor volume was an independent variable associated with longer survival in patients with glioblastoma multiforme (GBM) ( Table 1) . 2 The median survival for these patients was 13.4 months compared with 8.8 months for patients who had lesser resections (P<.0001). The pre-and post-operative magnetic resonance imaging (MRI) scans of these 416 patients with GBM were analyzed prospectively and volumetric data were collected to determine the extent of resection as accurately as possible. 3 This eliminated a drawback encountered in many studies in which nonquantitative and subjective descriptions, such as "gross total,""subtotal," and "partial," were used to describe the extent of surgical resection. [4] [5] [6] A multivariate analysis identified five independent predictors of survival, three of which were chosen for the outcome scale: tumor necrosis, patient age, and Karnofsky score ( Table 2) . Using this analysis, groups were created to allow survival estimation based on the scale according to the extent of resection (Table 3 ). For patients under 45 years of age with a Karnofsky score above 80 and no necrosis on their MRI scan, it is likely that these three factors outweigh the influence of the extent of resection; thus, a statistical difference was not found between the group with 98% or greater resection and the group with lesser resection. Also, the numbers for this younger group were too small to allow meaningful statistical analyses. The median survival in this group was nearly 3 years (35.3 months). A similar argument can also be applied to patients ≥65 years of age with a Karnofsky score of less than 80 and with necrosis on their MRI. Unfortunately, the median survival in this group of patients was less than 1 year (8.6 months).
This was not a randomized, controlled study, and thus the patients may have been partially "preselected" for better survival. That is, patients may have been selected for surgery if the treating surgeon believed that a maximal resection of the tumor was possible, whereas patients who were believed to have tumors that were not maximally resectable may not have been selected for surgery. Therefore, it is difficult to determine from a retrospective study whether the characteristics of the tumor or the extent of resection imparts a better prognosis in these patients. However, these two variables are closely related, and differentiating between them may be irrelevant from a practical perspective.
Relief of Mass Effect
Malignant gliomas are rapidly growing tumors that can reach large sizes prior to detection. In the M. D. Anderson series, 2 the median preoperative tumor volume at presentation was 34 cm 3 . Compared with patients with lesser resections, those undergoing gross total resections have been shown to have better neurologic outcomes on follow-up without added perioperative morbidity or mortality. 1, 7, 8 In addition, with the significant reduction in mass effect, it is our experience that patients with maximal resections tolerate radiotherapy better and experience fewer side effects.
Oncologic Advantage
Fewer cells remaining after resection of a tumor should improve prognosis because fewer cells will need to be eliminated by either adjuvant therapies or the body's own defenses. 9 Despite the fact that a 99% resection of a tumor mass consisting of 10 9 cells leaves 10 7 cells alive, a reduction in the number of cells that may be resistant to therapy, that may undergo further malignant transformation, or that may release growth factors and immune inhibiting agents is potentially advantageous. The limits of adjuvant therapies in terms of cellular thresholds of effectiveness are not known. Also, an important consideration is the ability to provide tissue from tumor samples for research purposes. Samples from human brain tumor tissue are needed to develop new therapies since it is unlikely that significant advances toward a cure for glioblastoma will be achieved using animal models alone.
Improved Diagnosis
Although some authors contend that stereotactic biopsy can be used to guide the management of gliomas, 10, 11 the discrepancy rate between the biopsy and the resected specimens is 38%, even with expert neuropathologic review. 12 These results are from a study of 81 consecutive patients at the M. D.Anderson Cancer Center, which found that the resulting discrepancy would have affected therapeutic regimens in 26% of cases and had prognostic implications in 38% of cases. Particularly in cases where a surgical resection of the lesion is possible, little is gained by performing a stereotactic biopsy prior to the open craniotomy unless an abscess, lymphoma, or other nonneoplastic lesion is likely.
Reasons for the Controversy
Extensive reviews have failed to find a statistical correlation between extent of surgical resection and survival in malignant gliomas. [13] [14] [15] Why is the concept of aggressive resection for glioblastoma still controversial, given the above arguments and the more recent studies? Several factors that surround the controversy have been identified:
Poor Prognosis of Malignant Gliomas
Despite recent surgical and technological advances, the prognosis for GBM has changed little over the last 20 years. The best average survival for all patients with GBM is still 16 to 18 months, which is similar to the survival average reported 20 years ago. 2, 16, 17 However, average survival as long as 3 years may occur in some patients who are younger, have a good Karnofsky performance status, and have lesions in favorable locations. 2 Bucy and colleagues 18 reported a case of a patient who underwent surgery in 1958 for a GBM who was alive 26 years later.
Invasiveness of Malignant Gliomas
Studies have shown that tumor cells may invade far beyond the main tumor mass into the brain due to the infiltrating nature of malignant gliomas and to the impossibility of removing all of the tumor cells. 19 Early studies have shown that even hemispherectomy is inadequate for the control of malignant gliomas. In the 1980s, Kelly et al 20 reported no survival advantage using volumetric laser resection but showed that patients with deep tumors could have the same survival as those with more superficial and more easily resectable tumors. While still controversial, this was the beginning of the concept that maximal resection could improve prognosis for malignant gliomas, an idea that has taken 15 more years to statistically demonstrate in a select group of patients.
Risk of Surgical Deficits
It is a falsely held belief by some that radical resection of malignant gliomas is associated with an increased incidence of neurologic morbidity compared with lesser resections, even when considering lesions in eloquent areas. 1, 7 Fadul et al 8 showed that patients undergoing radical resections were at no greater risk of being neurologically impaired at 1 week following surgery and had fewer acute neurologic complications than patients undergoing lesser resections. When examining the Karnofsky performance status in these two groups of patients,Ammirati and colleagues 7 found that the scores improved by a mean of 6.8 (P<.006) compared to preoperative scores in the completely resected group, while there was no improvement in the scores in the subtotally resected group (P<.002).
Lack of Statistically Sound Evidence
Other than the recent report from the M. D.Anderson Cancer Center, 2 no other studies have examined the relationship between the extent of surgical resection and survival using rigorous preoperative and postoperative imaging analysis in a prospective fashion. In most studies, the extent of resection was not confirmed with postoperative imaging 5, 6 or patients had undergone relatively few true maximal resections, 7, 21 and only one study was prospective. 21 The opinion of the surgeon at the time of surgery may be remarkably inaccurate, with only a 30% correlation with MRI. 21 Therefore, postoperative imaging is key in determining the extent of resection. In addition to not confirming the extent of resection on imaging, investigators for many of the studies considered a 90% resection to be gross total. This "dilutes" the category of complete resections and thus renders the study unable to identify the group with a better prognosis -that being the ≥98% resection group. Because of these drawbacks, two review studies of the literature prior to 1990 13, 14 and another after 1990 15 determined that "…little scientifically credible evidence is available to support the assertion that aggressive surgical resection prolongs survival." 15 Many authors have called for a prospective, randomized trial to clarify this issue, 9, [13] [14] [15] but it is unlikely that such a study will be conducted because a significant number of patients are required to determine a difference statistically and because many surgeons would not allow their patients to be randomized to such a trial.
Surgical Techniques and Adjunctive Technologies
The stages of a craniotomy to resect a malignant glioma should include appropriate preoperative and postoperative imaging, preoperative planning including location and size of the craniotomy, and intraoperative decision making. Intraoperative ultrasound and neuronavigation systems are also available to identify anatomical structures and dissection planes, as well as aid in the determination of the extent of resection.
High-quality imaging is necessary and should include MRI. The detail obtained with MRI is far superior to computed tomography (CT) in determining the exact anatomic location of the lesion, particularly the relationship with eloquent structures. Also, the high definition provided by MRI allows the surgeon to identify cystic or necrotic portions of the tumor that may not be visible on enhanced CT. This high definition can assist in the tumor dissection by allowing correlation of such structures on imaging with what is seen at open surgery. As well, MRI can identify residual tumor postoperatively more accurately than CT (Fig 1) . 21 Adjunctive imaging techniques such as functional MRI, spectroscopy, and positron emission tomography can aid in identifying the relationship of the tumor to eloquent areas and in the separation of tumor from edema from normal brain (Fig 2) . The use of these adjuncts varies depending on their availability and the location of the tumor mass.
Standard operative exposures are performed with or without utilizing neuronavigation for the location of the bone flap. Linear or curvilinear incisions as well as flaps are acceptable with regard to blood supply, cosmesis, and possible reoperation. A cortical incision or a corticectomy, depending on the location and size of the lesion, is made if the lesion is superficial. For deeper or smaller lesions, entrance through a sulcus, if possible, is preferred. Determining the location for such an incision into the brain requires knowledge of the anatomy of the region that may be significantly altered due to the distortion caused by the mass of tumor. Various surgical adjuncts are available to assist the surgeon is determining the pathologic anatomy, including ultrasound, 22 neuronavigation, 23 intraoperative CT 24 or MRI, 25,26 and somatosensory-evoked potential (SSEP) mapping 27 (Fig 3) . When the lesion is near speech or motor areas, the procedure can be performed with the patient awake to permit intraoperative stimulation mapping. 28 Regardless of the depth of the lesion, the dissection should be in the white matter plane outside of the lesion with the goal of circumferential dissection. 29 Subpial dissection is a useful technique around the margins as even malignant gliomas respect pial borders. 30 In some cases, identifying the correct plane can be challenging and requires a combination of the above surgical adjuncts. However, the surgeon's interpretation of the color and consistency of the tissue, together with knowledge of anatomy, is most important in determining where the resection will cease. The main goal of surgery is removal of the enhancing tissue, which should be possible even in functionally critical areas as there should be no neurons within the tumor itself. While this is generally true, approximately 7% of gliomas will have invaded eloquent areas without altering function, thus rendering aggressive resections potentially threatening to critical functions such as speech and motor areas. 31, 32 In most cases, an effective technique of tumor resection utilizes the suction and bipolar cautery since usually these tumors are soft and amenable to resection in this manner. 30 However, when the tumor is firm or fibrous, the ultrasonic aspirator is useful. A potential drawback with the ultrasonic aspirator is that it may aerosolize tumor cells, thus distributing them some distance from the original site, but the clinical significance of this is uncertain. 33 
Conclusions
With the advances in surgical techniques and perioperative technology, it is now possible to maximally resect malignant intrinsic glial neoplasms, even within functionally critical areas, without increased morbidity. Studies have demonstrated a survival advantage with 98% or greater resection of these lesions, particularly in younger patients with good Karnofsky scores. 
